Connect Biopharma Holdings LTD Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Kleanthis Xanthopoulos, a Director at Connect Biopharma Holdings Ltd, received 3,738 ordinary shares as compensation for his services.
NASDAQ
Connect Biopharma Holdings Ltd reports that Director Jean I Liu received 6,718 ordinary shares as compensation for her services.
NASDAQ
Director James Huang acquired 150,000 ordinary shares of Connect Biopharma Holdings Ltd. for approximately $356,610.
NASDAQ
Director Kleanthis Xanthopoulos acquired 2,816 ordinary shares of Connect Biopharma Holdings Ltd in lieu of cash compensation.
NASDAQ
Director Jean Liu acquired 5,061 ordinary shares of Connect Biopharma Holdings Ltd as compensation for board service.
NASDAQ
Connect Biopharma Director James Huang has filed a Form 4 indicating a planned indirect acquisition of 1.16 million ordinary shares at $3.45 each on March 31, 2026, under a 10b5-1 plan.